These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 15656586)
1. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation. Chang LC; Lee HF; Chung MJ; Yang VC Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586 [TBL] [Abstract][Full Text] [Related]
2. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man. Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826 [TBL] [Abstract][Full Text] [Related]
3. Strategies for improving the functionality of an affinity bioreactor. Wang T; Yang Z; Emregul E; David A; Balthasar JP; Liang J; Yang VC Int J Pharm; 2005 Dec; 306(1-2):132-41. PubMed ID: 16246511 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass. Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162 [TBL] [Abstract][Full Text] [Related]
5. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate. Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496 [TBL] [Abstract][Full Text] [Related]
6. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study. Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778 [TBL] [Abstract][Full Text] [Related]
7. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro. Bruins P; te Velthuis H; Eerenberg-Belmer AJ; Yazdanbakhsh AP; de Beaumont EM; Eijsman L; Trouwborst A; Hack CE Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model. Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Downing LJ; Stanley JC Lab Anim Sci; 1997 Apr; 47(2):153-60. PubMed ID: 9150494 [TBL] [Abstract][Full Text] [Related]
10. Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist. Cushing DJ; Cooper WD; Cohen ML; McVoy JR; Sobel M; Harris RB Eur J Pharmacol; 2010 Jun; 635(1-3):165-70. PubMed ID: 20307530 [TBL] [Abstract][Full Text] [Related]
11. A novel protamine variant reversal of heparin anticoagulation in human blood in vitro. Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Stoneham MD; Doyle AR; Zelenock GB; Jacobs LA; Shanley CJ; TenCate VM; Stanley JC J Vasc Surg; 1997 Dec; 26(6):1043-8. PubMed ID: 9423721 [TBL] [Abstract][Full Text] [Related]
12. Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine model. Lee LM; Chang LC; Wrobleski S; Wakefield TW; Yang VC AAPS PharmSci; 2001; 3(3):E19. PubMed ID: 11741270 [TBL] [Abstract][Full Text] [Related]
13. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT). Bode AP; Castellani WJ; Hodges ED; Yelverton S Thromb Haemost; 1991 Aug; 66(2):213-7. PubMed ID: 1771614 [TBL] [Abstract][Full Text] [Related]
14. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge. Balan S; Choi JW; Godwin A; Teo I; Laborde CM; Heidelberger S; Zloh M; Shaunak S; Brocchini S Bioconjug Chem; 2007; 18(1):61-76. PubMed ID: 17226958 [TBL] [Abstract][Full Text] [Related]
15. Neutralization of a low molecular weight heparin (LHN-1) and conventional heparin by protamine sulfate in rats. Diness V; Ostergaard PB Thromb Haemost; 1986 Dec; 56(3):318-22. PubMed ID: 3563964 [TBL] [Abstract][Full Text] [Related]
16. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes. Mao S; Neu M; Germershaus O; Merkel O; Sitterberg J; Bakowsky U; Kissel T Bioconjug Chem; 2006; 17(5):1209-18. PubMed ID: 16984130 [TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation. Sun X; Yang Z; Li S; Tan Y; Zhang N; Wang X; Yagi S; Yoshioka T; Takimoto A; Mitsushima K; Suginaka A; Frenkel EP; Hoffman RM Cancer Res; 2003 Dec; 63(23):8377-83. PubMed ID: 14678999 [TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene glycol)-conjugated human serum albumin including iron porphyrins: surface modification improves the O2-transporting ability. Huang Y; Komatsu T; Wang RM; Nakagawa A; Tsuchida E Bioconjug Chem; 2006; 17(2):393-8. PubMed ID: 16536471 [TBL] [Abstract][Full Text] [Related]
19. Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation. Massonnet-Castel S; Pelissier E; Bara L; Terrier E; Abry B; Guibourt P; Swanson J; Jaulmes B; Carpentier A; Samama M Haemostasis; 1986; 16(2):139-46. PubMed ID: 3710291 [TBL] [Abstract][Full Text] [Related]
20. Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation. Nielsen VG Ann Thorac Surg; 2006 May; 81(5):1720-7. PubMed ID: 16631662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]